sip on the turn, page-4

I have no idea why the sudden drop when the share price has been pretty much treading water with low volumes for the last month, despite wild swings in the general share market. They have a conference call on the 24/03 to discuss their full year results, and the full year report is due for release on the 25/03 (Ex. Dividend 01/04), I imagine the full year report will be available before trading resumes after the long weekend.

I mostly have speculative stocks, and bought into SIP a month ago on the basis of it returning a modest yield and being a steady performer over the long term. I will know on Tuesday whether they have at least performed steadily and met my expectations.


Brief report on ninemsn dated 20/03:-
"Credit Suisse rates as Neutral - Analysts from Credit Suisse believe that Sigma Pharmaceuticals needs to at least meet minimum guidance and demonstrate return on investments and the move to a new manufacturing facility, in order to re-establish market credibility. The company?s guidance is for net profit of $88-93m excluding interest costs related to its share buyback and one-off costs of restructuring and plant rationalisation. Analysts at Credit Suisse estimate a net profit of $86.2m for the current fiscal year. The company is in early turnaround according to the analysts who believe that with few short-term catalysts the stock?s evolution is likely to be protracted. They have retained the rating and target price."